Treatment of Aortic Arch Aneurysms with a Modular Transfemoral Multibranched Stent Graft: Initial Experience

Abstract Objectives To present initial experience with a new modular transfemoral multibranched stent graft for treating aortic arch aneurysms. Methods Six patients, considered high risk for open surgery, were treated with custom made branched stent grafts. All patients had a staged left carotid sub...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of vascular and endovascular surgery 2012-05, Vol.43 (5), p.525-532
Hauptverfasser: Lioupis, C, Corriveau, M.-M, MacKenzie, K.S, Obrand, D.I, Steinmetz, O.K, Abraham, C.Z
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Objectives To present initial experience with a new modular transfemoral multibranched stent graft for treating aortic arch aneurysms. Methods Six patients, considered high risk for open surgery, were treated with custom made branched stent grafts. All patients had a staged left carotid subclavian bypass before the endovascular procedure. Each branched graft had a 12 mm side branch for the innominate artery and an 8 mm side branch for the left common carotid artery. Results Four patients out of six had uneventful placement of the prostheses, with successful exclusion of their aneurysms. One patient developed a type I endoleak that was managed successfully with coiling and gluing of the aneurysm sac. In one patient, cannulation of the innominate branch was unsuccessful and an extra-anatomic bypass was necessary to perfuse the right carotid and vertebral arteries. This patient developed a stroke, while one more suffered a right cerebellar infarct. Conclusion We have demonstrated the technical feasibility of a modular transfemoral branched stent graft for treatment of aortic arch aneurysms. The method is relatively safe based on initial experience. More cases and long-term follow up are necessary to evaluate the efficacy and safety of this new device.
ISSN:1078-5884
1532-2165
DOI:10.1016/j.ejvs.2012.01.031